Elevate your product range with patented and scientifically validated probiotic strain LPLDL® in finished formulation formats dedicated to improving cardiometabolic health.
Each formulation utilises specialised active ingredients for a comprehensive, multi-targeted approach. Tackle key areas including Cholesterol, Hypertension, and Vascular Health with assurance, safety and scientific validation.
Contains LPLDL® as the active ingredient to support healthy cholesterol maintenance.
Supports maintenance of cholesterol
Supported by two double-blind placebo-controlled studies to:
4 synergistic ingredients help support normal blood circulation and pressure.
A clinical trial from the University of Pavia which documented statistically significant findings on blood pressure reduction:
A unique bi-layer tablet ensures a superior probiotic cell count survival in combination with previously non-compatible active ingredients
(Contributors of plaque formation and atherosclerosis)
Contains 3 ingredients LPLDL®, Thiamine (Vitamin B1) and K2VITAL® (Vitamin K2) to reduce plaque formation and atherosclerosis (hardening of the arteries).
Supporting EFSA health claim:
3 synergistic ingredients specifically chosen for their capacity to support the reduction of plaque formation and atherosclerosis
Harnesses the synergistic capabilities of 2 patented and scientifically validated ingredients, LPLDL® from ProBiotix Health and K2VITAL® from Kappa Biosciences
Shown in multiple studies to reduce key risk biomarkers of plaque formation and atherosclerosis:
Find out more about our finished product solutions containing LPLDL®